Your browser doesn't support javascript.
loading
Immune checkpoint blockade for non-small cell lung cancer: What is the role in the special populations?
Califano, R; Gomes, F; Ackermann, C J; Rafee, S; Tsakonas, G; Ekman, S.
Afiliación
  • Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK. Electronic address: raffaele.califano@christie.nhs.uk.
  • Gomes F; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Ackermann CJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Rafee S; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Tsakonas G; Department of Oncology-Pathology, Karolinska Institutet/Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Ekman S; Department of Oncology-Pathology, Karolinska Institutet/Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
Eur J Cancer ; 125: 1-11, 2020 01.
Article en En | MEDLINE | ID: mdl-31830688
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inmunoterapia / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inmunoterapia / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido